SIRT6 and Hepatic steatosis: The phosphorylation levels of AMPK at Thr172 and LKB1 at Ser428 were significantly increased by RGZ treatment (Figure 4), suggesting that the Sirt6-AMPK pathway may be involved in the beneficial effects of RGZ on hepatic steatosis.